Nurix Therapeutics (NRIX) Asset Utilization Ratio (2020 - 2026)

Nurix Therapeutics (NRIX) has 7 years of Asset Utilization Ratio data on file, last reported at 0.06 in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio fell 57.16% year-over-year to 0.06 in Q2 2026; TTM through May 2026 was 0.06, a 57.16% decrease from a year earlier, with the FY2025 full-year figure at 0.12, up 16.24% from the prior year.
• Asset Utilization Ratio for Q2 2026 stood at 0.06, down from 0.11 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for NRIX reached as high as 0.24 in Q1 2024 and fell as low as 0.06 in Q2 2026.
• Historically, Asset Utilization Ratio has averaged 0.13 across 5 years, with a median of 0.11 in 2024.
• Across the five-year window, Asset Utilization Ratio surged 163.05% in 2023 and tumbled 63.71% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.09 in 2022, then jumped by 163.05% to 0.23 in 2023, then slumped by 60.24% to 0.09 in 2024, then surged by 50.44% to 0.14 in 2025, then tumbled by 54.77% to 0.06 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.06 in Q2 2026, 0.11 in Q1 2026, and 0.14 in Q4 2025.